BridgeMD
Evaluation of the effect of para-sternal block on respiratory function after cardiac sternotomy surgery. Study prospective, controlled, randomized, single-blind study with independent assessment of outcome
EU CTIS ID: 2024-513301-30-00
What this study is testing
Compare the impact of locoregional anesthesia parasternal analgesic block on postoperative respiratory function at D1 postoperatively.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients over 18 years of age
- Elective cardiac surgery under CEC with sternotomy (valve replacement, coronary artery bypass graft or combined combined surgery with valve replacement and coronary bypass surgery)
- Patient's written informed consent
You likely can't join if
- Thoracotomy approach
- Autoimmune disorder
- Transplant recipient
- Inclusion in another study within the last 30 days
- Pregnancy
- Women of childbearing age should have a negative urine HCG pregnancy test
See the full eligibility criteria
- Patients over 18 years of age
- Elective cardiac surgery under CEC with sternotomy (valve replacement, coronary artery bypass graft or combined combined surgery with valve replacement and coronary bypass surgery)
- Patient's written informed consent
- Thoracotomy approach
- Autoimmune disorder
- Transplant recipient
- Inclusion in another study within the last 30 days
- Pregnancy
- Women of childbearing age should have a negative urine HCG pregnancy test
- Mini-sternotomy approach
- Opioid dependence or chronic medication opioid medication
- Chronic use of benzodiazepines (respiratory depressant or respiratory depressant or may affect respiratory function respiratory function)
- Contraindication or allergy to local anesthetics
- Emergency surgery
- Acute infectious endocarditis
- Immunosuppressive treatment or steroids (prednisone > 0.5mg/kg/day or equivalent)
- AIDS with CD4 count <200/mm3
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.